Patents by Inventor Edward Thomas Coulstock

Edward Thomas Coulstock has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • IL-7 Binding Proteins and Their Use in Medical Therapy
    Publication number: 20240025988
    Abstract: Provided herein are interleukin 7 (IL-7) binding proteins, pharmaceutical compositions and their use in the treatment or prevention of a disease or condition.
    Type: Application
    Filed: September 5, 2023
    Publication date: January 25, 2024
    Applicant: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Gerben BOUMA, Edward Thomas COULSTOCK, David DIXON, Stephanie HOPLEY, Alan Peter LEWIS, Jessica Lynn NEISEN
  • IL-7 binding proteins and their use in medical therapy
    Patent number: 11802150
    Abstract: Provided herein are interleukin 7 (IL-7) binding proteins, pharmaceutical compositions and their use in the treatment or prevention of a disease or condition.
    Type: Grant
    Filed: November 30, 2021
    Date of Patent: October 31, 2023
    Assignee: GlaxoSmith Kline Intellectual Property Development Limited
    Inventors: Gerben Bouma, Edward Thomas Coulstock, David Dixon, Stephanie Hopley, Alan Peter Lewis, Jessica Lynn Neisen
  • IL-7 Binding Proteins and Their use in Medical Therapy
    Publication number: 20220169717
    Abstract: Provided herein are interleukin 7 (IL-7) binding proteins, pharmaceutical compositions and their use in the treatment or prevention of a disease or condition.
    Type: Application
    Filed: November 30, 2021
    Publication date: June 2, 2022
    Inventors: Gerben BOUMA, Edward Thomas Coulstock, David Dixon, Stephanie Hopley, Alan Peter Lewis, Jessica Lynn Neisen